Gout treatment fails to win approval - Boston Globe

Visit Bulgaria

Gout treatment fails to win approval Boston Globe ... whose only drug lost patent protection in 2006, has failed to win US approval to sell a new gout treatment because regulators need more information. ... FDA Approves Gout Treatment After Long Years of UseMedPage Today Savient Pharma (SVNT) Lower On FDA Refusal of Gout Treatment, But ...StreetInsider.com (subscription) Savient Gout Drug Needs Added Info; Stock PlungesWall Street Journal PR Newswire (press release) -MedPage Today -Wall Street Journal all 72 news articles »

Ardea Biosciences to Present at the T... - MarketWatch (press release)

Ardea Biosciences to Present at the Thomas Weisel Partners ... MarketWatch (press release) RDEA594, our lead product candidate for the treatment of hyperuricemia and gout, is a selective URAT1 transporter inhibitor in Phase 2 clinical development. ... and more »

Gout and men - KHSL

Gout and men KHSL To diagnose gout, a doctor will typically measure the level of uric acid, and examine joint fluid samples for the presence of crystals. Treatment may begin ... Illness of aristocrats now attacks anyoneCalgary Herald all 9 news articles »

Gout Drug Krystexxa Held Up by FDA - About - News & Issues

Gout Drug Krystexxa Held Up by FDA About - News & Issues Krystexxa, formerly known as Puricase, is a drug being developed as a treatment option for patients unable to take conventional gout treatments (or who were ...